Dr. Brea C. Lipe, MD

Dr. Lipe practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Lipe's NPI, 1760542088, was assigned on December 8, 2006. Dr. Lipe graduated from Albany Medical College in 2005. Dr. Lipe holds New York license 282510.

Dr. Lipe's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Lipe's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Lipe to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lipe practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lipe's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lipe is licensed in New York.

CMS data shows 742 Medicare services from Dr. Lipe across 4 procedure codes in 2024, for 122 Medicare patients. Medicare paid $46,243 for them.

CMS counts 122 Medicare patients who saw Dr. Lipe in 2024. The largest group is 65 to 74, with 57 patients. 57% of them have high blood pressure, and 53% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lipe's median patient age at 71, with 43% women.

In 2024, Dr. Lipe wrote 344 Medicare Part D claims for 81 patients. 75% of them were for generic drugs. CMS names the drug for 263 of them, across 10 drugs with 11 or more claims each, at $1,017,011 in total drug cost. In 2023, CMS named 323 claims across 11 drugs.

Dr. Lipe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lipe as offering telehealth.

Dmand AI links 40 papers to Dr. Lipe, published from 2011 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Antibodies, Monoclonal, Humanized. Dr. Lipe has published most often in Clin Lymphoma Myeloma Leuk. Dr. Lipe's most frequent co-authors are Omar Salah Aljitawi, MD, Kenneth C. Anderson, MD and Ajai Chari, MD.

Dmand AI links Dr. Lipe to 8 clinical trials, 3 of them phase 1 studies. 5 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Leukemia, Plasma Cell.

CMS Open Payments shows 114 general payments to Dr. Lipe from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Sanofi and Genzyme US Companies paid the most, $67,509.

Dr. Lipe graduated from Albany Medical College in 2005.